An assessment of the knowledge, practices and resources during the delivery of malaria health care services among private health care practitioners: a cross section study in the Mid-Western Region of Uganda.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101088677 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6963 (Electronic) Linking ISSN: 14726963 NLM ISO Abbreviation: BMC Health Serv Res Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, [2001-
    • Subject Terms:
      Antimalarials*/therapeutic use ; Malaria*/diagnosis ; Malaria*/drug therapy; Artemether/therapeutic use ; Artemether, Lumefantrine Drug Combination/therapeutic use ; Cross-Sectional Studies ; Delivery of Health Care ; Health Facilities ; Humans ; Private Sector ; Uganda/epidemiology
    • Abstract:
      Background: Approximately 50 % of the population in Uganda seeks health care from private facilities but there is limited data on the quality of care for malaria in these facilities. This study aimed to document the knowledge, practices and resources during the delivery of malaria care services, among private health practitioners in the Mid-Western region of Uganda, an area of moderate malaria transmission.
      Methods: This was a cross sectional study in which purposive sampling was used to select fifteen private-for-profit facilities from each district. An interviewer-administered questionnaire that contained both quantitative and open-ended questions was used. Information was collected on availability of treatment aides, knowledge on malaria, malaria case management, laboratory practices, malaria drugs stock and data management. We determined the proportion of health workers that adequately provided malaria case management according to national standards.
      Results: Of the 135 health facilities staff interviewed, 61.48 % (52.91-69.40) had access to malaria treatment protocols while 48.89 % (40.19-57.63) received malaria training. The majority of facilities, 98.52 % (94.75-99.82) had malaria diagnostic services and the most commonly available anti-malarial drug was artemether-lumefantrine, 85.19 % (78-91), followed by Quinine, 74.81 % (67-82) and intravenous artesunate, 72.59 % (64-80). Only 14.07 % (8.69-21.10) responded adequately to the acceptable cascade of malaria case management practice. Specifically, 33.33 % (25.46-41.96) responded correctly to management of a patient with a fever, 40.00 % (31.67-48.79) responded correctly to the first line treatment for uncomplicated malaria, whereas 85.19 % (78.05-90.71) responded correctly to severe malaria treatment. Only 28.83 % submitted monthly reports, where malaria data was recorded, to the national database.
      Conclusions: This study revealed sub-optimal malaria case management knowledge and practices at private health facilities with approximately 14 % of health care workers demonstrating correct malaria case management cascade practices. To strengthen the quality of malaria case management, it is recommended that the NMCD distributes current guidelines and tools, coupled with training; continuous mentorship and supportive supervision; provision of adequate stock of essential anti-malarials and RDTs; reinforcing communication and behavior change; and increasing support for data management at private health facilities.
      (© 2021. The Author(s).)
    • References:
      Reprod Health. 2014 Sep 4;11 Suppl 2:S1. (PMID: 25209614)
      BMJ Qual Saf. 2014 Apr;23(4):290-8. (PMID: 24025320)
      Int J Equity Health. 2011 Aug 19;10:33. (PMID: 21854584)
      Med Trop (Mars). 2008 Feb;68(1):45-50. (PMID: 18478772)
      BMC Int Health Hum Rights. 2010 Nov 24;10:29. (PMID: 21106099)
      Malar J. 2018 Aug 22;17(1):305. (PMID: 30134987)
      Malar J. 2017 May 25;16(1):219. (PMID: 28545583)
      Educ Health (Abingdon). 2006 Nov;19(3):385-7. (PMID: 17178522)
      BMJ Glob Health. 2019 Jul 18;4(4):e001339. (PMID: 31406583)
      Malar J. 2017 Feb 14;16(1):76. (PMID: 28196532)
      PLoS One. 2014 Jul 30;9(7):e100039. (PMID: 25075742)
      Reprod Health. 2015 Apr 08;12:30. (PMID: 25884616)
      BJOG. 2009 Oct;116 Suppl 1:18-21. (PMID: 19740165)
      Trans R Soc Trop Med Hyg. 2008 Nov;102(11):1067-74. (PMID: 18565559)
      PLoS One. 2017 Mar 2;12(3):e0173093. (PMID: 28253315)
      Pan Afr Med J. 2012;13 Suppl 1:2. (PMID: 23467840)
      Soc Sci Med. 2003 Sep;57(5):937-48. (PMID: 12850118)
      BMC Res Notes. 2012 Jul 06;5:211. (PMID: 22551039)
      Malar J. 2016 Apr 14;15:212. (PMID: 27075477)
      Int J Gynaecol Obstet. 2016 Jan;132(1):117-25. (PMID: 26653397)
      Lancet. 2012 Oct 13;380(9850):1331-40. (PMID: 22999430)
      Asian Pac J Trop Biomed. 2014 Jun;4(6):498-504. (PMID: 25182953)
      Malar J. 2014 Jan 02;13:1. (PMID: 24383426)
      Am J Trop Med Hyg. 2017 Nov;97(5):1513-1523. (PMID: 29016322)
      Lancet. 2004 Apr 3;363(9415):1110-5. (PMID: 15064029)
      BMC Health Serv Res. 2011 Nov 11;11:307. (PMID: 22078071)
      Lancet. 2013 May 18;381(9879):1747-55. (PMID: 23683641)
      BMC Med Inform Decis Mak. 2014 May 13;14:40. (PMID: 24886567)
      Cad Saude Publica. 2006 Mar;22(3):561-70. (PMID: 16583100)
    • Contributed Indexing:
      Keywords: Malaria; Private health care workers
    • Accession Number:
      0 (Antimalarials)
      0 (Artemether, Lumefantrine Drug Combination)
      C7D6T3H22J (Artemether)
    • Publication Date:
      Date Created: 20210811 Date Completed: 20210812 Latest Revision: 20210814
    • Publication Date:
      20240105
    • Accession Number:
      PMC8356442
    • Accession Number:
      10.1186/s12913-021-06849-8
    • Accession Number:
      34376219